Maltecca Francesca, Magnoni Raffaella, Cerri Federica, Cox Gregory A, Quattrini Angelo, Casari Giorgio
Center for Genomics, Bioinformatics, and Biostatistics, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
J Neurosci. 2009 Jul 22;29(29):9244-54. doi: 10.1523/JNEUROSCI.1532-09.2009.
Paraplegin and AFG3L2 are ubiquitous nuclear-encoded mitochondrial proteins that form hetero-oligomeric paraplegin-AFG3L2 and homo-oligomeric AFG3L2 complexes in the inner mitochondrial membrane, named m-AAA proteases. These complexes ensure protein quality control in the inner membrane, jointly with a chaperone-like activity on the respiratory chain complexes. Despite coassembling in the same complex, mutations of either paraplegin or AFG3L2 cause two different neurodegenerative disorders. Indeed, mutations of paraplegin are responsible for a recessive form of hereditary spastic paraplegia, whereas mutations of AFG3L2 have been recently associated to a dominant form of spinocerebellar ataxia (SCA28). In this work, we report that the mouse model haploinsufficient for Afg3l2 recapitulates important pathophysiological features of the human disease, thus representing the first SCA28 model. Furthermore, we propose a pathogenetic mechanism in which respiratory chain dysfunction and increased reactive oxygen species production caused by Afg3l2 haploinsufficiency lead to dark degeneration of Purkinje cells and cerebellar dysfunction.
Paraplegin和AFG3L2是普遍存在的核编码线粒体蛋白,它们在线粒体内膜中形成异源寡聚体Paraplegin-AFG3L2和同源寡聚体AFG3L2复合物,称为m-AAA蛋白酶。这些复合物与呼吸链复合物上的伴侣样活性共同确保内膜中的蛋白质质量控制。尽管共同组装在同一复合物中,但Paraplegin或AFG3L2的突变会导致两种不同的神经退行性疾病。事实上,Paraplegin的突变是遗传性痉挛性截瘫隐性形式的病因,而AFG3L2的突变最近与显性形式的脊髓小脑共济失调(SCA28)相关。在这项工作中,我们报告了Afg3l2单倍体不足的小鼠模型概括了人类疾病的重要病理生理特征,因此代表了第一个SCA28模型。此外,我们提出了一种发病机制,其中Afg3l2单倍体不足导致的呼吸链功能障碍和活性氧产生增加会导致浦肯野细胞黑质变性和小脑功能障碍。